|
Stephen Infante is a partner in our New York office who focuses on mergers and acquisitions and private equity and also practices in the areas of corporate governance, securities, and finance. His experience includes public and private acquisitions and divestitures, “going private” transactions, recapitalizations, and other leveraged transactions, minority investments, cross-border transactions and joint ventures, as well as representation of investment banks as financial advisors in M&A transactions.
He represents clients in a variety of industries including life sciences, energy, software and technology, and communications and media.
Representative Matters
- Charlesbank Capital Partners in its investment in Universal Technical Institute in its acquisition and sale of Aurora Organic Dairy, in its acquisition and sale of The GSI Group, in acquisitions of Zenith Products, The Horn Companies, Cedar Creek Lumber, and Peacock Engineering Company, in its sale of American Tire Distributors, and in its formation of Blacksmith Brands, which purchased the Efferdent, Luden's and PediaCare brands from Johnson & Johnson, and subsequent sale of Blacksmith Brands to Prestige Brands.
- The Special Committee of the Board of Directors of Atlas Energy, L.P. in its acquisition of upstream oil and gas assets from its former parent, Atlas Energy, Inc., in connection with Chevron's purchase of Atlas Energy, Inc.
- SandRidge Energy in its $1.6 billion acquisition of Arena Resources and in its pending $1.275 billion acquisition of Dynamic Offshore Resources.
- Joy Global in its $1.1 billion acquisition of LeTourneau Technologies from Rowen Companies and the subsequent sale of LeTourneau's drilling systems business to Cameron International.
- Boehringer Ingelheim in its acquisition of certain animal health products being divested in connection with the Pfizer-Wyeth merger.
- Medarex in its $2.4 billion merger with Bristol-Myers Squibb.
- Kerr-McGee in its $18 billion merger with Anadarko Petroleum, in its defense and settlement of a proxy contest initiated by Carl C. Icahn and JANA Partners, in a $4 billion “Dutch” auction self tender offer and related spin-off of its chemicals business, and in its $3.4 billion acquisition of Westport Resources and related $650 million senior notes offering.
- The Special Committee of Independent Directors of Charlotte Russe on its $380 million acquisition by Advent International and its successful defense of a proxy contest initiated by KarpReilly LLC.
- JLG Industries in its $3.2 billion merger with Oshkosh Truck Corporation.
- Resource Capital in the restructuring of its investment in Leaf Commercial Capital undertaken in connection with an investment in Leaf by EOS Partners, L.P. and its affiliates.
- Abbott Laboratories in its $3.7 billion acquisition of KOS Pharmaceuticals, Inc.
- Paramount Acquisition Corp., a healthcare-focused special purpose acquisition company, in its acquisition of ChemRx, an institutional pharmacy.
- Biotechnology company, Encysive Pharmaceuticals, in its exploration of strategic alternatives, which resulted in the sale of the company to Pfizer.
- Intercel AG, an Austrian biotechnology company, in its acquisition of Iomai Inc., a publicly-traded vaccine developer.
|
|